ARTICLE | Company News
Protein Design Labs, Roche deal
September 20, 2004 7:00 AM UTC
The companies partnered to co-develop and co-commercialize PDLI's Zenapax daclizumab for asthma and related respiratory diseases. PDLI will receive $17.5 million up front and is eligible for up to $18...